Lei Gao

Dr. Lei Gao

4. Department of Bioinformatics, School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2023 in Biochemistry and Molecular Biology Education
Verified
Journal Article
Closed access
LGLei Gao
Lei Gao
MGMiao Guo
Miao Guo

8 April 2016 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
NLNan Liu
Nan Liu
CWChen Wang
Chen Wang
LWLibing Wang
Libing Wang
LGLei Gao
Lei Gao
HCHui Cheng
Hui Cheng
JWJianmin Wang
Jianmin Wang
Acute myeloid leukemia (AML) is an aggressive clonal malignancy of hematopoietic progenitor cells with a poor clinical outcome. The resistance of leukemia cells to contemporary chemotherapy is one of the most formidable obstacles to treating AML. Combining valproic acid (VPA) with other anti-leukemic agents has previously been noted as a useful and necessary strategy which can be used to specifically induce anticancer gene expression. In the present study, we demonstrated the synergistic antileukemic activities between VPA and cytarabine (Ara‑C) in a retrovirus-mediated murine model with MLL-AF9 leukemia, three leukemia cell lines (THP-1, K562 and HL-60) and seven primary human AML samples. Using RT-qPCR, we noted that the combination of VPA and Ara‑C significantly upregulated Bax expression and led to the arrest of leukemia cell proliferation, sub-G1 DNA accumulation and cell apoptosis, as demonstrated by flow cytometric analysis. Significantly, further experiments revealed that knockdown of Bax expression prevented VPA and Ara‑C‑induced cell apoptosis in THP-1 cells. The results of our present study demonstrated the synergistic antileukemic effect of combined VPA and Ara‑C treatment in AML, and thus we suggest that VPA be used an alternative treatment for AML.

4 March 2014 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
XSXianmin Song
Xianmin Song
XHXiaoxia Hu
Xiaoxia Hu
SLShuqing Lü
Shuqing Lü
LGLei Gao
Lei Gao
LCLi Chen
Li Chen
JWJianmin Wang
Jianmin Wang

17 September 2021 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
PDF file
HQHao-Xiang Qi
Hao-Xiang Qi
QSQi-Dong Shen
Qi-Dong Shen
HZHong-Yi Zhao
Hong-Yi Zhao
GQGuo-Zhen Qi
Guo-Zhen Qi
LGLei Gao
Lei Gao
Whether risk genes of severe coronavirus disease 2019 (COVID-19) from genome-wide association study could play their regulatory roles by interacting with host genes that were interacted with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins was worthy of exploration. In this study, we implemented a network-based approach by developing a user-friendly software Network Calculator (https://github.com/Haoxiang-Qi/Network-Calculator.git). By using Network Calculator, we identified a network composed of 13 risk genes and 28 SARS-CoV-2 interacted host genes that had the highest network proximity with each other, with a hub gene HNRNPK identified. Among these genes, 14 of them were identified to be differentially expressed in RNA-seq data from severe COVID-19 cases. Besides, by expression enrichment analysis in single-cell RNA-seq data, compared with mild COVID-19, these genes were significantly enriched in macrophage, T cell and epithelial cell for severe COVID-19. Meanwhile, 74 pathways were significantly enriched. Our analysis provided insights for the underlying genetic etiology of severe COVID-19 from the perspective of network biology.

25 August 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YLYu-Qin Lv
Yu-Qin Lv
XWXing Wang
Xing Wang
YJYu-Zhuang Jiao
Yu-Zhuang Jiao
YWYan-Hua Wang
Yan-Hua Wang
NWNa Wang
Na Wang
JZJing-Jun Zhang
Jing-Jun Zhang
Aanti-epileptic drugs have been used for treating epilepsy for decades, meanwhile, more than one hundred genes have been identified to be associated with risk of epilepsy; however, the interaction mechanism between anti-epileptic drugs and risk genes of epilepsy was still not clearly understood. In this study, we systematically explored the interaction of epilepsy risk genes and anti-epileptic drug targets through a network-based approach. Our results revealed that anti-epileptic drug targets were significantly over-represented in risk genes of epilepsy with 17 overlapping genes and P-value = 2.2 ×10 −16. We identified a significantly localized PPI network with 55 epileptic risk genes and 94 anti-epileptic drug target genes, and network overlap analysis showed significant interactome overlap between risk genes and drug targets with P-value = 0.04. Besides, genes from PPI network were significantly enriched in the co-expression network of epilepsy with 22 enriched genes and P-value = 1.3 ×10 −15; meanwhile, cell type enrichment analysis indicated genes in this network were significantly enriched in 4 brain cell types (Interneuron, Medium Spiny Neuron, CA1 pyramidal Neuron, and Somatosensory pyramidal Neuron). These results provide evidence for significant interactions between epilepsy risk genes and anti-epileptic drug targets from the perspective of network biology.

28 March 2023 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
YGYan Gao
Yan Gao
KCKai Chen
Kai Chen
JLJia-Ning Liu
Jia-Ning Liu
LYLiang-Jie Yuan
Liang-Jie Yuan
JZJing-Jun Zhang
Jing-Jun Zhang
LGLei Gao
Lei Gao